euro-gastroenterology-clinical-pharmacy-2019-keynote

3 / 5

Euro Gastroenterology 2019 & Clinical Pharmacy 2019 Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3
Page 21
March 25-26, 2019 | Amsterdam, Netherlands
&
GASTROENTEROLOGY AND HEPATOLOGY
4th International Conference on
CLINICAL PHARMACY & PHARMACY PRACTICE
9th World Congress on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
NON-ALCOHOLIC FATTY LIVER
DISEASE AND BACTERIAL
INFECTIONS
Non-alcoholic fatty liver disease (NAFLD) is a common chronic
and serious form of chronic liver disease worldwide. NAFLD rep-
resents a spectrum of chronic liver diseases that range from simple
steatosis to non-alcoholic steatohepatitis, cirrhosis, and hepatocellu-
lar carcinoma. Awareness for NAFLD as a multisystemic disease with
hepatic and extrahepatic involvement has increased. Major risk fac-
tors of NAFLD includes obesity and type 2 diabetes mellitus which
are associated with infections. Therefore, NFALD is considered a com-
ponent of metabolic syndrome. NAFLD is independently associated
with increased risk of cardiovascular diseases, type 2 diabetes mel-
litus, chronic kidney disease, malignancy, and bacterial infections.
Recently, it was shown that NAFLD is associated independently with
bacterial infections such as: Helicobacter pylori cellulitis, urinary tract
infections and pneumonia. In a large retrospective study it was re-
ported that NAFLD was associated with community-acquired pneu-
monia and with 30-day all-cause mortality. Moreover, this association
was more significant in patients with advanced hepatic fibrosis.
William Nseir, Arch Gen Intern Med 2019, Volume 3
DOI: 10.4066/2591-7951-C1-022
William Nseir, MD is a specialist in internal
medicine and infectious diseases. He is also
the director of internal medicine and consul­
tant in infectious diseases at the Baruch Pa­
deh Medical Center, Poryia, Israel and faculty
of medicine in Galilee, Bar-Ilan University,
Israel. Over the last ten years, he has focused
on scientific interest on the topics related to
the relationship between bacterial infections
and non-alcoholic liver disease including the
metabolic syndrome. His main research in­
terest is to explore the relationship between
the components of metabolic syndrome in-
cluding fatty liver and bacterial infections.
He has published several studies regarding
the relationship between obesity / NAFLD
and Clostridium difficile infection, recurrent
urinary tract infections, community-acquired
pneumonia, and other recurrent bacterial in-
fections.
William Nseir
Bar-Ilan University, Israel
BIOGRAPHY